Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results
Go back to Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results| (NASDAQ: OVID) | Delayed: 2.71 +0.02 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.69 | 52 Week High | $ | |||
| Open | $2.73 | 52 Week Low | $ | |||
| Day High | $2.76 | P/E | N/A | |||
| Day Low | $2.65 | EPS | $ | |||
| Volume | 1,183,520 | |||||

